Understanding the role of ursodeoxycholic acid and gut microbiome in non-alcoholic fatty liver disease: current evidence and perspectives

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, resulting in a huge medical burden worldwide. Accumulating evidence suggests that the gut microbiome and bile acids play pivotal roles during the development of NAFLD. Patients with NAFLD exhibit unique signatures of...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Qingyi Mao, Beibei Lin, Wenluo Zhang, Yu Zhang, Qian Cao, Mengque Xu
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Frontiers Media S.A. 2024-03-01
Rangatū:	Frontiers in Pharmacology
Ngā marau:	ursodeoxycholic acid gut microbiome bile acid receptors non-alcoholic fatty liver disease bile acid–gut microbiome axis
Urunga tuihono:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1371574/full
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!